Skip to content

Medical emergency? What to do

US advisers criticize FDA drug safety board

3-RXPublished February 15, 20062 min read

Key points

  • Some outside advisers on Friday criticized a major part of the government's efforts to improve drug safety, saying a new oversight board needs independent voices and should consider meeting in public.
  • Food and Drug Administration officials, plus experts from other government agencies.
  • Peter Gross, the advisory panel chairman, praised the FDA as "incredibly competent" but said the board would benefit from outside views.
  • The board was established in the wake of Merck & Co.

Some outside advisers on Friday criticized a major part of the government's efforts to improve drug safety, saying a new oversight board needs independent voices and should consider meeting in public.

The Drug Safety Oversight Board was announced a year ago as a step to help regulators quickly respond to signs of unexpected side effects after a drug reaches the market.

Board members are senior U.S. Food and Drug Administration officials, plus experts from other government agencies. They meet periodically in private to discuss how to address emerging issues. Brief summaries are released to the public.

The board is separate from other FDA drug safety activities and an external advisory panel that provides input on drug risks when the agency requests it.

Dr. Peter Gross, the advisory panel chairman, praised the FDA as "incredibly competent" but said the board would benefit from outside views.

"You are setting yourself up for failure with this oversight board," Gross told FDA officials at a meeting of the advisory panel. "In this age of transparency, you decide to have a committee that's responsible, according to its name, for overall safety, and yet it meets in private. You don't have public representatives."

The board was established in the wake of Merck & Co. Inc.'s recall of arthritis drug Vioxx and other safety controversies that sparked criticism of the FDA's oversight.

The board is a good step that "addresses some of the perceived weaknesses," said Dr. Curt Furberg, an adviser from Wake Forest University School of Medicine in North Carolina.

Arthur Levin, director of the Center for Medical Consumers, said the board's name is misleading. "I don't think it's a drug safety board...The model is bad, the name is bad. Why can't there be an audience?"

FDA officials said the board was designed to be an internal management group, in part because officials must discuss confidential company information.

Adding nongovernment members would require a lengthy screening process for conflicts of interest that could delay action on important issues, they added.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underDrug News

Keep reading

Cancer

Experimental drug shrinks cancer tumors

An experimental cancer drug successfully shrank tumors in patients with different kinds of cancer, including typically hard-to-treat lung cancers, according to a new study. Oncologists said the research was…

4 min read

Cancer

Avastin Slows Resistant Ovarian Cancer

Progression of platinum-resistant ovarian cancer slowed by more than 50% in patients who received bevacizumab (Avastin) plus chemotherapy compared with nonplatinum chemotherapy alone, results of a randomized trial…

3 min read

Drug News

Prevnar trial results needed for CDC recommendation

Advisors to the U.S. Centers for Disease Control and Prevention on Wednesday will wait for results from a trial of Pfizer Inc's Prevnar 13 pneumonia vaccine before deciding whether to recommend its use in all adults…

1 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.